Product

Company

NCT05149170·1 site·ClinicalTrials.gov

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Chinese Academy of Medical Sciences

With

Age

18–70

Sex

ALL

Healthy volunteers

Not accepted

Other mature T- or NK- lymphoma
Hemophagocytic lymphohistiocytosis
Primary CNS lymphoma or CNS-involved lymphoma
History of malignancy except for cutaneous basal-/squamous- cell carcinoma or cervical carcinoma in situ 3 years prior to study treatment

The record

StatusUnknown

PhasePhase 2

Taking part30

StartedOct 2021

UpdatedDec 8, 2021

Conditions

Where1

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Beijing, Beijing Municipality, China

Clareo Health | Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL